Biotricity Inc
NASDAQ:BTCY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its Industry Average (29.4), the stock would be worth $0.03 (86% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 214 | $0.23 |
0%
|
| Industry Average | 29.4 | $0.03 |
-86%
|
| Country Average | 14.5 | $0.02 |
-93%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
$30.1m
|
/ |
Jan 2026
$141.2k
|
= |
|
|
$30.1m
|
/ |
Mar 2026
$-4.1m
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
|
Biotricity Inc
NASDAQ:BTCY
|
6.3m USD | 214 | -1.3 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 43.2 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
26.8B USD | 21.2 | 29.5 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.7B AUD | 77.8 | 62.8 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 12.3 | 20.8 | |
| SE |
|
Sectra AB
STO:SECT B
|
51.8B SEK | -134.4 | 97 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.9B USD | 23.3 | 42.3 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 15.7 | 18.8 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 4 290.1 | -328 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
19B CNY | -120.1 | -61.5 | |
| US |
H
|
Heartflow Inc
NASDAQ:HTFL
|
2.8B USD | 0 | 0 |
Market Distribution
| Min | 0 |
| 30th Percentile | 10.6 |
| Median | 14.5 |
| 70th Percentile | 20.6 |
| Max | 3 794.4 |
Other Multiples
Biotricity Inc
Glance View
Biotricity, Inc. is a medical technology company, which is focused on biometric data monitoring solutions. The company is headquartered in Redwood City, California and currently employs 44 full-time employees. The company went IPO on 2015-10-26. The firm developed its Bioflux MCT technology, comprised of a monitoring device and an ECG reporting software component. The Bioflux device is comprised of a wet electrode and worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patient’s electrocardiogram (ECG) data for monitoring and diagnostic purposes. Both the device and software are in accordance with mobile cardiac telemetry (MCT) billing code standards, compliant with arrhythmia devices and alarms, and require 510000 clearance, which has been obtained. The Bioflux device has been developed, among other things, with global system for mobile communications (GSM) mobile chip for global cellular network compatibility; touch-screen liquid crystal display (LCD) viewer; and extended battery pack for an additional approximately 48 hours of battery life.
